Humacyte (HUMA)
NASDAQ:HUMA
US Market
Holding HUMA?
Track your performance easily

Humacyte (HUMA) Technical Analysis

801 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
3Neutral
12Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Humacyte’s (HUMA) Moving Averages Convergence Divergence (MACD) indicator is -0.42, suggesting Humacyte is a Buy.
Humacyte’s (HUMA) 20-Day exponential moving average is 5.83, while Humacyte’s (HUMA) share price is $5.44, making it a Sell.
Humacyte’s (HUMA) 50-Day exponential moving average is 6.28, while Humacyte’s (HUMA) share price is $5.44, making it a Sell.

Humacyte (HUMA) Pivot Points

Sep 20, 2024, 05:00 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.93
5.06
5.15
5.28
5.37
5.50
5.59
Fibonacci
5.06
5.15
5.20
5.28
5.37
5.42
5.50
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Humacyte (HUMA) Moving Averages

Sep 20, 2024, 05:00 AM
Period
Simple
Exponential
MA5
5.42Sell
5.38Sell
MA10
5.42Sell
5.51Sell
MA20
5.88Sell
5.83Sell
MA50
6.90Sell
6.28Sell
MA100
6.44Sell
6.02Sell
MA200
4.84Buy
4.93Buy
Humacyte’s (HUMA) 10-Day exponential moving average is 5.51, while Humacyte’s (HUMA) share price is $5.44, making it a Sell.
Humacyte’s (HUMA) 100-Day exponential moving average is 6.02, while Humacyte’s (HUMA) share price is $5.44, making it a Sell.
Humacyte’s (HUMA) stock price is $5.44 and Humacyte’s (HUMA) 50-day simple moving average is 6.90, creating a Sell signal.
Humacyte’s (HUMA) stock price is $5.44 and Humacyte’s (HUMA) 100-day simple moving average is 6.44, creating a Sell signal.
Humacyte’s (HUMA) stock price is $5.44 and Humacyte’s (HUMA) 200-day simple moving average is 4.84, creating a Buy signal.

Humacyte (HUMA) Technical Indicators

Sep 20, 2024, 05:00 AM
Name
Value
Implied Action
RSI (14)
39.08
Neutral
STOCH (9,6)
18.14
Buy
STOCHRSI (14)
9.04
Buy
MACD (12,26)
-0.42
Buy
ADX (14)
16.33
Buy
Williams %R
-86.11
Buy
CCI (14)
-67.12
Neutral
ATR (14)
0.48
-
Ultimate Oscillator
37.95
Neutral
ROC
-17.21
Sell
Humacyte’s (HUMA) Relative Strength Index (RSI) is 39.08, creating a Neutral signal.
Humacyte’s (HUMA) Trend Strength Indicator (ADX) is 16.33, creating a Buy signal.
Humacyte’s (HUMA) Commodity Channel Index (CCI) is -67.12, creating a Neutral signal.
Humacyte’s (HUMA) Price Rate of Change (ROC) is -17.21, creating a Sell signal.

FAQ

Is HUMA a Buy, Hold, or Sell?
Based on HUMA’s technical indicators, HUMA is a Sell.
    What is HUMA’s RSI (14)?
    HUMA’s RSI (14) is 39.08, which suggests HUMA is a Neutral.
      What is HUMA’s MACD?
      HUMA’s MACD is -0.42, which suggests HUMA is a Buy.
        What is HUMA’s 5-day moving average?
        HUMA’s 5-day moving average is 5.42, which suggests HUMA is a Sell.
          What is HUMA’s 20-day moving average?
          HUMA 20-day moving average is 5.88, which suggests HUMA is a Sell.
            What is HUMA’s 50-day moving average?
            HUMA’s 50-day moving average is 6.90, which suggests HUMA is a Sell.
              What is HUMA’s 200-day moving average?
              HUMA’s 200-day moving average is 4.84, which suggests HUMA is a Buy.
                What is HUMA’s Williams % R (14)?
                HUMA’s Williams % R (14) is -86.11, which suggests HUMA is a Buy.
                  What is HUMA’s CCI (14)?
                  HUMA’s CCI (14) is -67.12, which suggests HUMA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis